Press ReleasesLifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings LimitedPR Newswire
Press ReleasesLifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)PR Newswire
Press ReleasesLifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Broadway Financial Corporation, Cancer Genetics, Inc., Proteostasis Therapeutics, Inc., Rosetta Stone Inc., and Yintech Investment Holdings LimitedPR Newswire
Press ReleasesLifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Jernigan Capital, Inc., Momenta Pharmaceuticals, Inc., NTN Buzztime, Inc., Principia Biopharma Inc., Spring Bank Pharmaceuticals, Inc., Varian Medical Systems, Inc., and Yintech Investment Holdings LimitedPR Newswire
SPY$393.840.53%
QQQ$337.24%
DOW$59.01-7.3%
GME$53.33-42%
NVCR$192.1711%
PLUG$64.6929%
PSTG$29.3314%
VIV$9.0410%
SPY$393.840.53%
QQQ$337.24%
DOW$59.01-7.3%
GME$53.33-42%
NVCR$192.1711%
PLUG$64.6929%
PSTG$29.3314%
VIV$9.0410%
AboutDeveloperContact
Telegram
StockTwits
Discord